Bavarian Nordic
Mr. Debruyne is a Belgian national, born in 1963.
Former President Global Vaccines at GSK where he was a member of GSK’s Corporate Executive Team, a business leader with more than 30 years’ experience in the life sciences industry.
Current positions: Professor of Practice at the University of Leuven, Faculty of Medicine, Biomedical Sciences Group and serves as non-executive director of the boards of University Hospitals UZ Leuven and Fund Plus. Member of the Institutional Advisory Board at VIB, the Life Sciences Board at Greenlight Biosciences Inc., Chair of the Portfolio Strategy and Management Board of CEPI and Strategy Advisor to the CEO.
Special competences: End-to-end knowledge within the life sciences industry and specifically within vaccines. Extensive board and management experience from publicly traded and private international life science companies.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Bavarian Nordic
8 followers
Bavarian Nordic A/S is a biotechnology company specializing in research, development and manufacture of active cancer immunotherapies and vaccines for infectious diseases.